New research by the Medicines and Healthcare products Regulatory Agency (MHRA) in partnership with the GSK Vaccines Institute ...
Morning Overview on MSN
Scientists want to catch mirror life before anyone builds it, using the trick behind 3D glasses
A proposed test for mirror life would read the handedness of living cells by the way they glow, using the same property of ...
Cloud-Clone Copeptin ELISA kits deliver critical quantitative evidence supporting the landmark neuroendocrine crosstalk ...
A peer-reviewed study of 230 human clinical samples found that a CRISPR-assisted nanodroplet assay identified NTM species and ...
The next major breakthrough in life sciences may have a company’s name attached to it, but increasingly, the story behind ...
Revolune today announced a partnership with Concept Life Sciences to help biopharma and life sciences customers reassess, transfer, and ...
Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2026. Third ...
A new study combining network pharmacology, molecular docking, and H9C2 cell experiments found that low-dose Ponatinib ...
The cobas smart e immunoanalyser – the newest addition to Roche’s industry-leading cobas immunoassay systems portfolio – is ...
The Thermo Fisher Scientific Junior Innovators Challenge Finals Week (Thermo Fisher JIC) is underway in Washington, D.C.
15h
SEKISUI Diagnostics Announces 510(k) Clearance and Launch of the OSOM® COVID-19/Flu A&B Combo Test
SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a 510(k) cleared rapid test to detect COVID-19 and Flu A&B in professional healthcare settings.
Expansion strengthens 360biolabs' Australian laboratories and supports early-phase clinical development with continuity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results